ArticleInternational journal of molecular sciences2024

Novel Findings on CCR1 Receptor in CNS Disorders: A Pathogenic Marker Useful in Controlling Neuroimmune and Neuroinflammatory Mechanisms in Parkinson's Disease.

Alberto Repici et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.